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Effect of Continuous Infusion of Relaxin on Progesterone, Oxytocin, and
Relaxin Blood Concentrations and Time of Parturition in Beef Heifers
Abstract
These studies were designed to determine whether continuous intravenous infusion of increasing dosages of
porcine relaxin during late pregnancy in beef heifers would influence circulating blood concentrations of
relaxin, progesterone, and oxytocin, and time of onset of parturition. Beef heifers were bred by artificial
insemination and, on Day 277, fitted with indwelling jugular cannulas for hormone infusion and blood
sampling from Day 277 to 286. Intravenous infusion of purified porcine relaxin (pRLX, 3000 U mg-1) was
started in heifers (n = 8) at increasing dosages (200 U h-1 on Days 277 and 278, 300 U h-1 on Days 279 and
280, 500 U h-1 on Day 281, 600 U h-1 on Day 282, and 700 U h-1 on Days 283 to 286). Phosphate buffer
saline (PBS, 10 ml h-1) was infused during these same times to control (n = 6) animals. Relaxin treatment
steadily increased the circulating plasma concentration of immunoreactive relaxin to more than 120 ng ml-1
compared with less than 0.5 ng ml-1 in PBStreated controls. Relaxin infusion in increasing dosages over the
treatment time was associated with a significant decrease (P < 0.01) in plasma progesterone concentration
compared with the PBS controls. Plasma levels of oxytocin at 4- hour intervals remained similar (P > 0.05)
during the pretreatment period and throughout continuous infusion of pRLX and PBS. Although continuous
intravenous infusion of relaxin resulted in a decrease in circulating blood levels of progesterone, it did not
significantly reduce the interval between the beginning of pRLX treatment and parturition compared with the
PBS-infused control heifers. These results indicate that continuous intravenous infusion of high levels of
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Summary
These studies were designed to determine
whether continuous intravenous infusion of
increasing dosages of porcine relaxin during late
pregnancy in beef heifers would influence
circulating blood concentrations of relaxin,
progesterone, and oxytocin, and time of onset of
parturition. Beef heifers were bred by artificial
insemination and, on Day 277, fitted with
indwelling jugular cannulas for hormone
infusion and blood sampling from Day 277 to
286. Intravenous infusion of purified porcine
relaxin (pRLX, 3000 U mg-1) was started in
heifers (n  = 8) at increasing dosages (200 U h- 1
on Days 277 and 278, 300 U h-1 on Days 279 and
280, 500 U h-1 on Day 281, 600 U h-1 on Day
282, and 700 U h-1 on Days 283 to 286).
Phosphate buffer saline (PBS, 10 ml h-1) was
infused during these same times to control (n  =
6) animals. Relaxin treatment steadily increased
the circulating plasma concentration of im-
munoreactive relaxin to more than 120 ng ml- 1
compared with less than 0.5 ng ml-1 in PBS-
treated controls. Relaxin infusion in increasing
dosages over the treatment time was associated
with a significant decrease (P < 0.01) in plasma
progesterone concentration compared with the
PBS controls. Plasma levels of oxytocin at 4-
hour intervals remained similar (P > 0.05)
during the pretreatment period and throughout
continuous infusion of pRLX and PBS.
Although continuous intravenous infusion of
relaxin resulted in a decrease in circulating
blood levels of progesterone, it did not
significantly reduce the interval between the
beginning of pRLX treatment and parturition
compared with the PBS-infused control heifers.
These results indicate that continuous
intravenous infusion of high levels of porcine
relaxin resulted in a decrease in progesterone
secretion in late pregnant beef heifers.
Introduction
Relaxin (RLX), a peptide hormone with partial struc-
tural homology to insulin, is produced in abundant quanti-
ties by corpora luteal on the ovaries during late pregnancy in
the pig. Relaxin induces marked cervical dilation, pelvic
relaxation, separation of the pubic symphysis, and
interpubic ligament formation in several mammalian
species. Although the pig is a rich source of this hormone,
only a single copy of the RLX-like gene with a short open
reading frame corresponding to part of the relaxin A-chain is
present in sheep; however, there is recent evidence of a
RLX-like hormone in granulosa cells of ovarian follicles in
cattle. Ruminants do respond to intravenous or intramus-
cular injection of porcine relaxin, however, by hormone-
specific quiescence of uterine muscle activity and by cervical
softening and dilation in cattle and sheep.
The objective of the present study was to determine the
effects of continuous infusion of increasing dosages of
porcine relaxin for several days on hormone secretion
profiles associated with late pregnancy and on parturition in
beef heifers. These periparturient hormones include
progesterone, oxytocin, and immunoreactive relaxin.
Materials and Methods
Animals
Fourteen primiparous crossbred beef heifers approaching
their first calving were bred by artificial insemination at
estrus (Day 0) from 171 - 189 Julian days. Gestation
averaged 283 days in this herd. During the early stages of
pregnancy (spring, summer, and fall) heifers were maintained
on pasture at the Rhodes Research Farm. The heifers were
fed a ration of mixed silage supplemented with hay during
the winter months. On Day 275, the heifers were transferred
to the Animal Reproduction Laboratory at Ames, acclimated
in confinement pens for hormone treatments and calving,
and fed corn (2.3 kg animal-1 day-1), hay and fresh water ad
libitum.
Experimental Groups
The experimental design is presented in Figure 1. On
Day 275, heifers were assigned randomly to one of two
treatment groups: porcine relaxin (pRLX), n = 8; and
phosphate buffer saline controls (PBS), n = 6. They were
bilaterally fitted with indwelling catheters into the external
jugular veins.
The control group received a continuous infusion of
0.01 molar phosphate buffer saline (PBS) pH 7.0 at a rate of
10 ml h-1. Relaxin used in this study was extracted and
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purified from ovaries of pregnant pigs. Highly purified
porcine relaxin (pRLX, 3000 U mg-1) was dissolved in 0.01
M PBS, pH 7.0, and infused in a graded dosage scheme.
Infusion pumps were calibrated to deliver 10 ml h-1. The
duration of pRLX or PBS infusion was 10 days, beginning
6 days before expected parturition at 06:00 hours and
terminating at either parturition or Day 286, if parturition
had not occurred.
The relaxin was infused in graded dosages throughout
the time course of the experiment (Figure 1). The dosage
schedule for the pRLX group was as follows: 200 U h-1 of
pRLX on Days 277 and 278; 300 U h-1 on Days 279 and
280; 500 U h-1 on Day 281; 600 U h-1 on Day 282; and 700
U h-1 on Day 283 (estimated parturition), until the end of
treatment. The control group was infused with PBS from
Day 277 through Day 286. The heifers were monitored
continuously to precisely determine the time of parturition,
dystocia, calf birth weight, and placental delivery. Dystocia
was evaluated on the basis of number and percentage of
heifers requiring assistance. Dystocia score was defined as: 1
= none, 2 = hand pull, 3 = chain-hand pull, 4 = chain-jack
pull, 5 = Caesarean section, and 6 = feteotomy.
Radioimmunoassay of Progesterone, Relaxin, and Oxytocin
in Peripheral Plasma
Hourly blood samples (10 ml) were collected via a
jugular catheter beginning at 06:00 hours before pRLX or
PBS infusion began. Blood was collected in 16 x 100 mm
heparinized vacutainors, maintained on ice up to 1 hour, and
centrifuged (2000 x g). Plasma from these samples was
frozen and stored at -20° C for radioimmunoassay (RIA) of
progesterone, relaxin, and oxytocin.
Progesterone was determined in duplicate 200-ml
aliquots of plasma with RIA by our procedures using a fully
characterized antibody. The minimal detectable concentration
of progesterone was 0.25 ng ml-1. The inter- and intra-assay
coefficients of variation were 8.9 (n = 9) and 10.5% (n =
36); nonspecific binding was 3.1%.
Immunoreactive relaxin was determined in duplicate
aliquots of 25 - 100 ml plasma in a double antibody RIA by
using 125I-labeled monotyrosylated pRLX and antiporcine
relaxin serum using the procedure we previously described.
Assay sensitivity was 35 pg ml-1 plasma. Intra-assay
variances were 2.90, 1.80, 3.22, 1.18, and 1.15%,
respectively. Interassay mean comparisons of relaxin in
RLX-treated and PBS-control heifers was 1.10 –  0.03 ng ml-
1
 with a covariance of 5.90% (n = 5).
Oxytocin extracted from plasma was quantified by a
sensitive RIA method using synthetic oxytocin for the stan-
dard curve, oxytocin antibody (from Professor D. Schams;
Technische Universität, München, Germany, K#8, E.15 1.7
g) and labeled oxytocin (100 ml; 3000 cpm 100 ml-1; 125I-
OT NEX-187, 2200 Ci mM-1, NEN Research Products,
DuPont, Wilmington, DE). The maximum binding was 42 -
44%, nonspecific binding was 1.0 - 1.6%, and assay
sensitivity was 0.01 pg tube-1. Intraassay coefficients of
variation of two internal standards were 13.7 and 18.6% (n =
4). Interassay coefficient of variation was 7.0% (n = 4).
Statistical Analysis
Experimental units were the individual cows, and they
were randomly assigned to treatments. Data were analyzed
with a split plot analysis of variance, and the general linear
model and Student's t-test for continuous variables were used
for comparisons between treatment groups. Hormone
treatment was the main plot, with time subplots for
evaluation of time and time x treatment interaction.
Results and Discussion
Effect of Relaxin on Parturition in Beef Heifers
Continuous infusion of increasing dosages of purified
pRLX (range from 4800 - 16 800 U 24 h-1) into primipa-
rous beef heifers during late pregnancy did not affect day of
calving as compared with the controls receiving an infusion
of PBS (P > 0.05) (Table 1). The duration of delivery was
similar in pRLX- and PBS-treated heifers (Table 1). Only
two of the fourteen pRLX- and PBS-treated heifers required
manual assistance for calf delivery. Dystocia score did not
differ between the two groups. There was no incidence of
retained placentae beyond 24 hours postpartum in
experimental or control heifers. Calves from dams in both
treatment groups were considered normal.
Effect of Continuous Infusion of pRLX on Plasma Concen-
trations of Immunoreactive Relaxin
Peripheral plasma concentrations of immunoreactive
relaxin in these late pregnant beef heifers are presented in
Figure 2. Pretreatment concentrations of immunoreactive
relaxin remained similar (P > 0.05) between pRLX and PBS
groups (0.4 –  0.07 and 0.3 –  0.02 ng ml-1). Immunoreactive
relaxin in the PBS control heifers did not change 1 hour after
treatment (0.3 –  0.01 ng ml-1) until the end of the PBS
infusion 216 hours later (0.3 –  0.01 ng ml-1). However,
continuous infusion of pRLX resulted in increased
immunoreactive relaxin concentration in peripheral plasma
(P < 0.01) as the dosage of pRLX (U h-1) was increased.
Mean plasma concentrations of immunoreactive relaxin
during each successive pRLX dosage infused were
significantly different (P < 0.001; 4.4 –  0.35 ng ml-1 at 300
U h-1; 9.3 –  0.75 ng ml-1 at 300 U h-1; 21 –  2.0 ng ml-1 at
500 U h-1; 33 –  4.3 ng ml-1 at 600 U h-1) with a peak of 77
–  4 ng ml-1 during the infusion of 700 U h-1 of pRLX.
Mean concentrations of immunoreactive relaxin in PBS
control heifers were significantly lower during infusion of
pRLX at dosages of 200 - 700 U h-1.
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Effect of Continuous Infusion of pRLX on Peripheral Plas-
ma Progesterone Concentrations
Changes in progesterone concentrations in peripheral
blood plasma are presented in Figure 3. During the pre-
treatment period, mean (–  SE) progesterone concentrations
were 4.2 –  0.38 ng ml-1 with a range of 2.2 to 7.2 ng ml-1
in the 14 beef heifers. Mean deviations of progesterone from
pretreatment means remained similar (P > 0.05) among both
groups before the infusion of pRLX or PBS. Progesterone
decreased (P < 0.05) during continuous infusion of 500 -
700 U h-1 pRLX compared with PBS controls. The rate of
change in progesterone levels between 300, 600, and 700 U
h-1 pRLX and PBS groups differed (P < 0.05).
Effect of Continuous Infusion of pRLX on Peripheral Plas-
ma Oxytocin Concentrations
Oxytocin levels at 4-h intervals remained similar (P >
0.05) during the pretreatment period and throughout
continuous infusion of pRLX and PBS (Figure 4). Oxytocin
in control heifers peaked at 0.95 –  0.10 pg ml-1 during the
72 hours before parturition, corresponding to infusion of
500 - 600 U h-1 in the pRLX-treated group, which peaked at
0.77 –  0.07 pg ml-1. Plasma oxytocin increased
simultaneously during the corresponding infusion period of
200 - 500 U h-1 in the PBS-control heifers (P < 0.05), and
during the same period in the pRLX-treated heifers (P <
0.01). In one control heifer, a spike release of oxytocin (3.8
pg ml-1) was detected, but no peak releases of oxytocin were
determined in any other heifers in that group.
The main finding was that continuous intravenous
infusion of purified pRLX at increasing dosages ranging
from 200 - 700 U h-1 over several days significantly de-
creased plasma progesterone concentration but did not result
in earlier parturition compared with PBS-infused control
heifers. Continuous infusion of pRLX into late pregnant
beef heifers maintained greatly elevated circulating relaxin
concentrations to parturition. This imposed RLX profile in
cattle mimicked the endogenous prepartum profiles of
circulating concentrations of relaxin found in other species,
such as the pig. Increasing circulating concentrations of
endogenous relaxin during late pregnancy have been shown
to be associated with unimpaired normal parturition in this
species, as evidenced by an increased number of stillborns
when pigs are treated with antiporcine relaxin antibody. In
cattle, relaxin given intramuscularly at a rate of 6000 U on
Day 275 resulted in a transient decrease in circulating
progesterone concentration and earlier calving. The
continuous infusion of high dosages of pRLX in the present
study may have decreased uterine myometrial activity. In
contrast to previous findings, gestation was not shortened in
the present study. Thus a single injection of pRLX too
many days before expected parturition or continuous
infusion of high dosages of pRLX for several days did not
result in earlier calving. In the present study, there was no
incidence of retained placentae in either group, and calving
was similar in both RLX- and PBS-treated heifers.
A temporal relationship exists between the graded rise
in plasma relaxin concentration and the abrupt decrease in
progesterone in response to infused porcine relaxin. This is
consistent with our earlier findings in which a significant
decrease in circulating progesterone occurred as early as 24
hours after deposition of relaxin in a gel into the cervical os
on Day 278, and again, at 90 minutes after intramuscular
injection on Day 273. The dosage, time, and route of relaxin
treatment are crucial in determining whether complete luteal
demise or temporary suppression of luteal progesterone
secretion without induction of parturition will occur in
cattle.
It has been postulated that oxytocin of luteal cell origin
may play a role in the regression of the bovine corpus
luteum. In the present study, plasma oxytocin
concentrations increased near parturition but were similar
when compared with PBS-treated controls. No spike releases
of oxytocin were detected as compared with our prior studies,
in which a bolus intravenous or intramuscular injection of
relaxin (i.e., up to 9000 U) induced single and multiple
peaks of oxytocin that ranged from 10-42 picograms per
milliliter; peak relaxin concentrations occurred within 30
minutes after hormone treatment. However, oxytocin peaks
in the present study may not have been detected because of
the infrequency of plasma sampling. Furthermore, the
infusion of increasing dosages of relaxin may have subdued
oxytocin peak releases during the 216 hours of continuous
pRLX treatment. It has been shown that oxytocin is released
intermittently, and in cattle plasma oxytocin levels appear to
be low or undetectable during late pregnancy but high during
the expulsive phase of labor. The discrepancies between
these results may relate to the origin of endogenous
oxytocin, whether the source is hypothalamic or luteal. In
summary, the results presented here indicate that the
continuous infusion of porcine relaxin during late pregnancy
results in a decrease in progesterone secretion in cattle.
Implications
Although continuous intravenous infusion of in-
creasing dosages of purified porcine relaxin over
several days significantly decreased plasma pro-
gesterone concentration, it did not induce earlier
parturition compared with phosphate buffer saline-
infused control beef heifers.
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Figure 1. Experimental design for late pregnant
beef heifers intravenously infused with porcine
relaxin (pRLX) or phosphate-buffered saline
(PBS) .
Figure 2. Immunoreactive relaxin concentration
(ng ml-1) in peripheral plasma of beef heifers
during continuous intravenous infusion of
porcine relaxin (pRLX, 3000 U mg-1, n  = 8) or
phosphate buffer saline (PBS, n  = 6) from Days
277 to 286 of pregnancy. Values are mean –  SE.
Figure 3. Progesterone concentration in
peripheral plasma (ng ml-1) during 100 h before
parturition in relaxin (pRLX, 3000 U mg-1, n  =
8) and phosphate buffer saline (PBS, n  = 6)
intravenous infusion. Values are mean –  SE.
Figure 4. Oxytocin concentration (pg ml-1) in
peripheral plasma during continuous intravenous
infusion of increasing dosages of porcine relaxin
(pRLX, 3000 U mg-1, n  = 8) and phosphate
buffer saline (PBS, n  = 6) in late pregnant beef
heifers from time of parturition (0 h). Values
are mean –  SE.
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Table 1. Effect of continuous infusion of porcine relaxin on duration of pregnancy in beef heifers.
aPorcine relaxin (3,000 U mg-1) dissolved in 0.01 M PBS was infused continuously from Day 277 to
parturition at increasing dosages from 200 - 700 U h-1. Controls received a continuous infusion of













       Dystocia        No.
    Score
pRLX 8 282 –  1.4 131 –  20 87 –  15 2 2.6 –  0.42
PBS 6 281 –  1.3 102 –  26 76 –  18 0  2.5 –  0.34
